At TechCrunch Disrupt in October 2026, Science Corporation CEO Max Hodak announced the company had implanted its PRIMA vision-restoring chip into the first Stargardt disease patient, who received the implant at Sydney Eye Hospital in Australia in May. Hodak described retinal prostheses as a type of brain-computer interface and outlined plans to expand BCI technology to broader medical applications. PRIMA is already commercially available in Europe for geographic atrophy patients.
Looktech, a brand under Chehui Technology, unveiled its next-generation AI smart glasses at SILMO Paris, claiming them to be the world's first AI glasses with a brain-computer interface. The product integrates EEG sensors, motion and light sensors, and a WUQI Micro audio chip, supporting health monitoring and AI interactions, with a total weight under 30 grams.
In the VOICE trial, Neuralink patient Terry is using his implant to help fine-tune a brain-to-voice interface powered by Grok Voice. He trained the algorithm by miming speech, then by thinking words and hearing them in his own natural voice.